GlassScriptPhysician profile
Maher D Abu-Hamdan
NPI 1144431503
$10,935.40
in general payments reported to CMS, 2019-2025
20 companies · $1,639 in 2025
The $1,639 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,767 · 2020: $508 · 2021: $747 · 2022: $2,138 · 2023: $1,798 · 2024: $1,339 · 2025: $1,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,032 · Travel and Lodging: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,032.49 |
| Travel and Lodging | $743.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,969.99 | 2023-2025 | Inspire |
| Intersect Ent, INC. | $2,042.29 | 2019-2021 | |
| Stryker Corporation | $1,563.41 | 2019-2022 | |
| Medtronic, INC. | $1,533.54 | 2022-2024 | Pteye Parathyroid Detection System, Sinuva |
| Optinose US, INC. | $939.68 | 2019-2024 | |
| Genzyme Corporation | $857.87 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $302.51 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $266.49 | 2021-2025 | Nucala |
| Aerin Medical INC. | $180.05 | 2024 | |
| Acclarent, INC | $48.79 | 2023-2024 | Acclarent Aera |
| Genentech USA, INC. | $35.58 | 2023-2024 | Xolair |
| Merck Sharp & Dohme LLC | $31.79 | 2023-2025 | Keytruda |
| Zimmer Biomet Holdings, INC. | $29.48 | 2020-2024 | Traumaone |
| Novartis Pharmaceuticals Corporation | $28.54 | 2019 | |
| Alk-Abello, INC | $27.31 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.41 | 2023 | Watchman Access System |
| Olympus America INC. | $15.06 | 2022 | |
| Bolder Surgical, LLC | $14.64 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.71 | 2019 | |
| Ethicon US, LLC | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Abu-Hamdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.